Hosted on MSN11h
Bayer Backs New Effort to Shield Weedkiller From Claims It Failed to Warn of Cancer
A renewed and expanded effort from chemical giant Bayer to shield itself from lawsuits that claim its popular weedkiller ...
The Pharma Letter13h
Kerendia: Bayer’s big opportunity to deliver for millions of patients, across indications
An interview with Bayer's Bernardo Kanahuati, senior vice president, global head cardiorenal and product team lead, Kerendia, and Katja Rohwedder, senior medical affairs physician, global medical ...
The Waterloo-Cedar Falls Courier2d
Last Roundup: Bill to shield Bayer from lawsuits draws protesters to Iowa Capitol
Legislation pending in Iowa and at least seven other states would protect pesticide companies from claims they failed to warn ...
J.P. Morgan Reaffirms Their Hold Rating on Bayer (0P6S)
J.P. Morgan analyst Richard Vosser maintained a Hold rating on Bayer (0P6S – Research Report) today and set a price target of €25.00. The ...
MM&M3d
Bayer’s Super Bowl ad tackles denial in heart disease
In its See Your Risks campaign, Bayer takes aim at denial among millennials and Gen Xers when it comes to heart disease. To ...
FiercePharma3d
Bayer brings heart health message to Super Bowl, warning millennials to open their eyes to risks
Bayer is worried about your heart health. | Older millennials, take note: Bayer is worried about your heart health. The drugmaker set out its concerns in an ad for aspirin, showing how people are ...
Recursion Pharmaceuticals’ (RXRX) AI Approach to Drug Discovery Shows Progress
Recursion Pharmaceuticals (RXRX) is a clinical-stage biotechnology company utilizing artificial intelligence to expedite drug ...